Nov 11, 2025, 08:10 by

MadeAi launched new capabilities to streamline and accelerate global value dossier (GVD) and Joint Clinical Assessment (JCA) submissions from within its MadeAi(TM) GenAI-powered platform—streamlining literature review from protocol creation to regulatory-ready reporting.

Nov 11, 2025, 08:10 by

• Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins • Broadens Amperia’s applications across recombinant protein research, screening, and development • Abselion to showcase kit alongside Amperia platform at PEGS Europe in Lisbon, Portugal from 11–13 November

Nov 11, 2025, 01:01 by User Not Found

Clinical Research News | It is no secret that clinical trial protocols have grown increasingly complex, resulting in longer study durations, higher costs, and greater burden on patients and investigative sites. It has been a consistent, well-documented trend for more than two decades now.

Nov 6, 2025, 07:55 by

Nov 6, 2025, 01:01 by User Not Found

Clinical Research News | Developing a “super-tolerable” weight loss drug is one of the biggest challenges in obesity medicine today. Researchers recently reported the creation of a promising molecule, tridecaneuropeptide (TDN), which reduces food intake without triggering the awful side effects often associated with glucagon-like peptide-1 (GLP-1) drugs such as Ozempic and Zepbound.

Nov 5, 2025, 01:01 by User Not Found

Clinical Research News | Developing a “super-tolerable” weight loss drug is one of the biggest challenges in obesity medicine today. Researchers recently reported the creation of a promising molecule, tridecaneuropeptide (TDN), which reduces food intake without triggering the awful side effects often associated with glucagon-like peptide-1 (GLP-1) drugs such as Ozempic and Zepbound.

Nov 4, 2025, 01:00 by User Not Found

Clinical Research News | At SCOPE Europe, Allison Proffitt hosted a panel of pharmaceutical industry leaders to discuss the real-world implementation of artificial intelligence in clinical trials, moving beyond theoretical benefits to address practical challenges and measurable outcomes.

Oct 30, 2025, 08:34 by

• Offers UK academic research institutions improved access to Primerdesign’s real-time PCR assays and reagents with reliable, fast and local support • SLS to showcase Primerdesign portfolio at Lab Innovations in Birmingham, UK (29–30 October)

Oct 30, 2025, 08:34 by

EazeBio has announced a strategic partnership with the University of California, Santa Cruz to advance and commercialize a groundbreaking instrument-free diagnostic platform.

Oct 29, 2025, 01:01 by User Not Found

Clinical Research News | Pangaea Data announces a collaboration with Microsoft; Ipsen acquires ImCheck Therapeutics; Flatiron Health released first-of-their-kind advances in LLM-extracted progression data and other uses; and more.

Oct 28, 2025, 01:00 by User Not Found

Clinical Research News | Kailera Therapeutics advances injectable dual GLP-1/GIP receptor agonist; Almac Group plans Almac Trial Coordinator, a first-in-class interoperable clinical trial technology platform; Elvara advances their upcoming phase 2 clinical trial of its lead candidate ELV001; and more.

Oct 24, 2025, 01:01 by User Not Found

Clinical Research News | Imagine that you’re a life sciences researcher tasked with answering a regulatory request that involves extracting meaningful data from over 200 clinical trial reports from various sources. You’re looking for patient demographics, study outcomes, adverse events, and dosage information. For decades, the industry has relied on manual effort, but GenAI agents enable far better unstructured data extraction.

Oct 23, 2025, 08:16 by

Oct 23, 2025, 08:16 by

Ansa Biotechnologies announced the global launch of its 50kb Clonal DNA product, the longest sequence-perfect synthetic DNA commercially available.

Oct 23, 2025, 08:16 by

Recognized for Global Precision Health Informatics Industry Excellence in Best Practices

Oct 22, 2025, 07:09 by

Upperton, UK-based CDMO (Contract, Development & Manufacturing Organisation) has increased its high precision filling capability with the installation and commission of the Fill2Weight gravimetric powder filling machine from 3P Innovation. Enhancing the CDMO capability of solid oral dose and dry powder medicines

Oct 22, 2025, 07:09 by

Partnership simplifies digital data flows between Veeva RIM and Certara’s CoAuthor™ generative AI solution for regulatory and medical writing

Oct 22, 2025, 01:01 by User Not Found

Clinical Research News | European clinical research is at a critical crossroads, industry leaders warned last week at SCOPE Europe. Regulatory fragmentation, site readiness challenges, and prolonged approval timelines are driving sponsors to more competitive markets in Asia and the United States.

Oct 21, 2025, 11:41 by User Not Found

Clinical Research News | Researchers at the Medical University of South Carolina (MUSC) are using a “super-simple” natural language processing (NLP) tool to streamline clinical research for metastatic brain cancer, a field where rapid advances in therapy are outpacing traditional methods of data analysis.

Oct 21, 2025, 08:50 by